Biotech

All Articles

J &amp J goes down period 2 dengue prospect in newest switch from injections

.Johnson &amp Johnson's deprioritization of its own contagious illness pipeline has claimed one more...

Relay sheds 10% of team after earlier cutbacks in July

.Preciseness medication biotech Relay Therapies is actually dropping around 10% of its own staff in ...

Pentixapharm ratings $22M IPO to deposit radiopharma tests

.Pentixapharm has actually introduced just about 20 million euros ($ 22 million) from an IPO, with t...

Lundbeck touches Charles River for AI-enabled neuro medicine discovery

.Lundbeck has utilized Charles Stream Laboratories' expert system functionalities to assist the brea...

Big pharma, biotech 'will not necessarily be actually symbiotic' in artificial intelligence: S&ampP

.Large Pharma is actually spending greatly in artificial intelligence to slash growth timelines and ...

I &amp I biotech Triveni increases $115M for preclinical antitoxins

.Triveni Bio has actually trapped $115 million in series B funds to accelerate preclinical antitoxin...

IGM turns coming from cancer to autoimmune, agitating C-suite

.IGM Biosciences finished in 2014 laying off personnel and also improving its own cancer cells pipe....

Shattuck centers CD47 plan over unstable effectiveness information, lays off 40% of personnel and sheds Ono work

.Shattuck Labs has knocked one more nail in to the coffin of CD47. After viewing a "reasonable" effe...

BioMarin goes Backpacking, striking RNA cope with biotech

.BioMarin is adding combustion to the R&ampD fire, striking a complement along with CAMP4 Therapies ...

Cash- strapped Gritstone begins seek strategic substitutes as cancer cells vaccination records underwhelm

.Gritstone bio has actually brought in banks to discover "potential value-maximizing tactics" after ...